Michael J Brownstein

Azevan Pharmaceuticals, Inc.

$9,854,619

Attributed

$14,080,951

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2010–25

$5M$3.8M$2.5M$1.3M$0

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$14,080,951 · 6

By mechanism

R44$7,694,953 · 3

U44$5,635,109 · 1

R43$501,472 · 1

SB1$249,417 · 1

Top collaborators

Most similar at Azevan Pharmaceuticals, Inc.

Same institution · by research overlap

Eve Marie Damiano$1,021,700

Others in their field

Top investigators on “Pharmaceutical Preparations”

Sonia M Thomas · Research Triangle Institute$701,865,642
Tracy L Nolen · Research Triangle Institute$474,487,152
David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947

Research focus

Pharmaceutical PreparationsSmall Business Innovation Research GrantProgramsReceptorOralVasopressinsPre-ClinicalPharmacotherapyNovel TherapeuticsBaseSafetyStructureDoseAdverse EffectsFundingDrug DevelopmentOrphan DrugsClinical TreatmentPharmacologic SubstanceDrug KineticsBiologicalBrainExhibitsBiology